National Healthcare Properties, Inc.
For the period ended Dec 31, 2025. Filed Feb 20, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 20, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| NATIONAL HEALTHCARE PROPERTIES, INC. | |
| By | /s/ Michael Anderson |
| Michael Anderson | |
| Chief Executive Officer and President(Principal Executive Officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Name | Capacity | Date |
|---|---|---|
| /s/ Leslie D. Michelson | Non-Executive Chair of the Board of Directors, Independent Director | February 20, 2026 |
| Leslie D. Michelson | ||
| /s/ Michael Anderson | Chief Executive Officer, President and Director | February 20, 2026 |
| Michael Anderson | (Principal Executive Officer) | |
| /s/ Andrew T. Babin | Chief Financial Officer and Treasurer | February 20, 2026 |
| Andrew T. Babin | (Principal Financial Officer) | |
| /s/ Ailin Park | Chief Accounting Officer | February 20, 2026 |
| Ailin Park | (Principal Accounting Officer) | |
| /s/ Elizabeth K. Tuppeny | Independent Director | February 20, 2026 |
| Elizabeth K. Tuppeny | ||
| /s/ Edward G. Rendell | Independent Director | February 20, 2026 |
| Edward G. Rendell | ||
| /s/ B.J. Penn | Independent Director | February 20, 2026 |
| B.J. Penn | ||
| /s/ Scott W. Humphrey | Independent Director | February 20, 2026 |
| Scott W. Humphrey | ||
| /s/ Edward M. Weil, Jr. | Director | February 20, 2026 |
| Edward M. Weil, Jr. | ||
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID 238) | F-2 |
|---|---|
| Consolidated Balance Sheets as of December 31, 2025 and 2024 | F-4 |
| Consolidated Statements of Operations and Comprehensive Loss for the Years Ended December 31, 2025, 2024 and 2023 | F-5 |
| Consolidated Statements of Changes in Equity for the Years Ended December 31, 2025, 2024 and 2023 | F-6 |
| Consolidated Statements of Cash Flows for the Years Ended December 31, 2025, 2024 and 2023 | F-7 |
| Notes to Consolidated Financial Statements | F-9 |
| Financial Statement Schedule: | |
| Schedule III — Real Estate and Accumulated Depreciation as of December 31, 2025 | F-38 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.